The latest closing stock price for AN2 Therapeutics as of September 18, 2024 is 1.06.
An investor who bought $1,000 worth of AN2 Therapeutics stock at the IPO in 2015 would have $-977 today, roughly -1 times their original investment - a -34.15% compound annual growth rate over 9 years.
The all-time high AN2 Therapeutics stock closing price was 61.75 on January 26, 2018.
The AN2 Therapeutics 52-week high stock price is 22.22, which is 1996.2% above the current share price.
The AN2 Therapeutics 52-week low stock price is 0.87, which is 17.9% below the current share price.
The average AN2 Therapeutics stock price for the last 52 weeks is 8.28.
An investor who bought $1,000 worth of AN2 Therapeutics stock at the IPO in 2015 would have $-977 today, roughly -1 times their original investment - a -34.15% compound annual growth rate over 9 years.
The all-time high AN2 Therapeutics stock closing price was 61.75 on January 26, 2018.
The AN2 Therapeutics 52-week high stock price is 22.22, which is 1996.2% above the current share price.
The AN2 Therapeutics 52-week low stock price is 0.87, which is 17.9% below the current share price.
The average AN2 Therapeutics stock price for the last 52 weeks is 8.28.